Invo Bioscience Inc (OTCMKTS:IVOB) released its earnings results on Monday, May 15th. The company reported $0.00 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The business had revenue of $0.05 million during the quarter.
Invo Bioscience (IVOB) opened at 0.345 on Tuesday. Invo Bioscience has a 52-week low of $0.20 and a 52-week high of $0.45. The firm has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.33. The company’s market cap is $48.71 million.
WARNING: “Invo Bioscience Inc (IVOB) Issues Quarterly Earnings Results” was published by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/06/06/invo-bioscience-inc-ivob-issues-quarterly-earnings-results-updated-updated.html.
About Invo Bioscience
INVO Bioscience, Inc is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company’s product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC).
What are top analysts saying about Invo Bioscience Inc? – Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts’ recommendations for for Invo Bioscience Inc and related companies.